Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Bristol-Myers Squibb, Celgene Corporation, Clovis Oncology, Genentech, Lilly, Merck & Co., Inc., and Novartis Pharmaceuticals Corporation.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

2nd Annual Miami Lung Cancer Conference™

2nd Annual Miami Lung Cancer Conference™


February 28, 2015
Fontainebleau Miami Beach
4441 Collins Avenue
Miami Beach, FL 33140

Overview

The Miami Lung Cancer Conference™ is a one-day meeting which will serve as an update on advances in the field and will focus on the future of lung cancer treatment including: molecular subsets, targeted agents in development, immunotherapies in development, treatment options in early stage, and a look forward from the experts.

The Conference is led by our chair, Thomas J. Lynch, Jr, MD, a leading expert in lung cancer. Participants will learn from engaging presentations delivered by thought leaders and by reviewing and discussing realistic and complex scenarios, sharing clinical experiences, understanding well-established and emerging unmet therapeutic opportunities, solving clinical problems, and clarifying best practices. Participants will actively respond to and interact with the faculty through informal questions and open discussion, and will leave with a higher level of understanding than they would otherwise achieve as a result of this approach.


Target Audience

This educational activity is directed toward medical oncologists and fellows who manage and treat patients with lung cancer. Surgical oncologists, radiation oncologists, and pulmonologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of lung cancer may also participate.


Learning Objectives

At the conclusion of this activity, participants should be better prepared to:

  • Summarize guidelines from CAP, ASCO, and NCCN regarding both mutational analysis and use of molecularly targeted agents for patients with non-small cell lung cancer (NSCLC)
  • Compare and contrast the clinical outcomes of first- and second-generation EGFR inhibitors and ALK inhibitors for patients with NSCLC across all lines of therapy
  • Assess how emerging data on the use of molecularly targeted agents can be used to improve the treatment of patients with NSCLC
  • Review recent data on immune-checkpoint inhibition with anti-PD-1, anti-PD-L1, and anti-CTLA-4 blockade
  • Summarize the factors to be considered when making treatment sequencing decisions, including efficacy of a drug at different stages, prior therapies, existing comorbidities, disease characteristics, and the need for molecular testing
  • Compare the efficacy and safety of chemotherapy with or without an angiogenesis inhibitor for the first-line treatment of advanced NSCLC
  • Describe the NSCLC maintenance therapy standards of care and current options for improved patient outcomes applying multitargeted antifolate, antiangiogenesis, and anti-EGFR strategies


Program Chair

Thomas J. Lynch, Jr., MD
Director, Yale Cancer Center
Physician-in-Chief, Smilow Cancer Hospital at Yale-New Haven
Richard and Jonathan Sackler Professor of Internal Medicine
New Haven, CT




Program Director

Heather A. Wakelee, MD
Associate Professor, Medicine(Oncology)
Stanford University Medical Center
Stanford, CA









Become a Member

Forgot Password?
Filter By